GOOD10: The Pandemic Issue explores big-picture ways that science innovation and communication can usher in a more equitable, more progress-oriented, and safer world.
The GOOD10 format explores fundamental issues facing humanity through the lenses of ten forces pushing the needle toward progress: Places, Philanthropists, Celebrities, Whistleblowers, Companies, Media, Products, Politicians, Scientists, and Actions. Across these categories, we seek to present unexpected and encouraging paradigms emerging from this historic crisis.
TABLE OF CONTENTS:
55 Lessons Learned About Science Communication Around the World; Quarantining Our Way Into Outer Space
Quarantining Our Way Into Outer Space
An Exclusive Interview with Wendy Schmidt about Science in the Pandemic Era
Neil deGrasse Tyson Wants Celebrities to Promote Scientists
The Science Sleuths Holding Fraudulent Research Accountable
The Biggest Challenge for a COVID-19 Vaccine: Making It Accessible and Affordable
Isaac Asimov on the History of Infectious Disease—And How Humanity Learned To Fight Back
Will COVID-19 Pave the Way For DIY Precision Medicine?
Will the Pandemic Propel STEM Experts to Political Power?
Would a Broad-Spectrum Antiviral Drug Stop the Pandemic?
Pseudoscience is Rampant: How Not to Fall For It
How COVID-19 Could Usher In a New Age of Collective Drug Discovery
"The Pandemic Science Summit" focused on how science innovation is key to society's future stability as we emerge from the pandemic, featuring:
Christopher Bailey – Arts and Health Lead, World Health Organization
Elisabeth Bik, Ph.D. – Microbiologist and scientific integrity consultant
Margaret Hamburg, M.D. – Foreign Secretary, National Academy of Medicine; former Commissioner, U.S. Food and Drug Administration
Peggy Oti-Boateng, Ph.D. – Director, Division of Science Policy and Capacity- Building, UNESCO
George Yancopoulos, M.D., Ph.D. – President and Chief Scientific Officer, Regeneron Pharmaceuticals
In July 1956, a new drug hit the European market for the first time. The drug was called thalidomide – a sedative that was considered so safe it was available without a prescription.
Sedatives were in high demand in post-war Europe – but barbiturates, the most widely-used sedative at the time, caused overdoses and death when consumers took more than the recommended amount. Thalidomide, on the other hand, didn't appear to cause any side effects at all: Chemie Grünenthal, thalidomide's manufacturer, dosed laboratory rodents with over 600 times the normal dosage during clinical testing and had observed no evidence of toxicity.
The drug therefore was considered universally safe, and Grünenthal supplied thousands of doctors with samples to give to their patients. Doctors were encouraged to recommend thalidomide to their pregnant patients specifically because it was so safe, in order to relieve the nausea and insomnia associated with the first trimester of pregnancy.
Niko von Glasow, born in 1960, is a German film director and producer who was born disabled due to the side effects of thalidomide.
Sarah Watts is a health and science writer based in Chicago. Follow her on Twitter at @swattswrites.